Abstract |
Effective, sensitive, and reliable diagnostic reagents are of paramount importance for combating the ongoing coronavirus disease 2019 (COVID-19) pandemic when there is neither a preventive vaccine nor a specific drug available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It will cause a large number of false-positive and false-negative tests if currently used diagnostic reagents are undermined. Based on genotyping of 31,421 SARS-CoV-2 genome samples collected up to July 23, 2020, we reveal that essentially all of the current COVID-19 diagnostic targets have undergone mutations. We further show that SARS-CoV-2 has the most mutations on the targets of various nucleocapsid (N) gene primers and probes, which have been widely used around the world to diagnose COVID-19. To understand whether SARS-CoV-2 genes have mutated unevenly, we have computed the mutation rate and mutation h-index of all SARS-CoV-2 genes, indicating that the N gene is one of the most non-conservative genes in the SARS-CoV-2 genome. We show that due to human immune response induced APOBEC mRNA (C > T) editing, diagnostic targets should also be selected to avoid cytidines. Our findings might enable optimally selecting the conservative SARS-CoV-2 genes and proteins for the design and development of COVID-19 diagnostic reagents, prophylactic vaccines, and therapeutic medicines. AVAILABILITY: Interactive real-time online Mutation Tracker.
|
Authors | Rui Wang, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei |
Journal | Genomics
(Genomics)
Vol. 112
Issue 6
Pg. 5204-5213
(11 2020)
ISSN: 1089-8646 [Electronic] United States |
PMID | 32966857
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | Copyright © 2020 Elsevier Inc. All rights reserved. |
Chemical References |
- Coronavirus Envelope Proteins
- DNA Primers
- envelope protein, SARS-CoV-2
|
Topics |
- COVID-19
(virology)
- COVID-19 Testing
- Coronavirus Envelope Proteins
(genetics)
- DNA Primers
- Genotyping Techniques
- Humans
- Mutation
- Polymorphism, Single Nucleotide
- SARS-CoV-2
(genetics, isolation & purification)
|